Benzinga | Nov 4, 2020 08:32AM EST

Morgan Stanley Maintains Equal-Weight on Pacific Biosciences, Raises Price Target to $12

Morgan Stanley maintains Pacific Biosciences (NASDAQ:PACB) with a Equal-Weight and raises the price target from $7 to $12.